William Terry, MD
Urology · Johnson City, TNNPI 1134380496
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,472 of the $12,029 with a category attached, or 62.1%. It is spread thinly across 46 manufacturers, the largest accounting for just 19.0%. Reporting peaked in 2024 at $3,446 and has fallen 67.8% since, to $1,111 in 2025.
Across 322 payments — averaging $37.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Procept Biorobotics Corporation$2K
- Micro-tech Endoscopy USA, Inc.$2K
- Coloplast$601
- Sumitomo Pharma America, Inc.$550
- Johnson & Johnson$539
- plus $4K from 40 others
Across 1 payment — averaging $7000.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Cornerstone Urology Network, LLC$7K
What the payments were for
- Consulting fees$1,50012%
- Travel & lodging$2,98625%
- Food & beverage$7,47262%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$1,820
- AMS$1,412
- INTERSTIM$265
- TITAN$152
- CAMCEVI$147
- CVAC Aspiration System$137
- SPACEOAR VUE$125
How this compares
$12,029 in reported general payments places this provider in the 75th percentile of 276 urology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 51 | $714,496 |
| ErleadaApalutamide | 44 | $623,968 |
| OrgovyxRelugolix | 111 | $290,302 |
| GemtesaVibegron | 122 | $84,348 |
| Abiraterone Acetate | 19 | $18,872 |
| MyrbetriqMirabegron | 17 | $9,659 |
| Methenamine Hippurate | 39 | $3,247 |
| Estradiol | 39 | $3,232 |
| Tamsulosin Hcl | 319 | $2,968 |
| Finasteride | 161 | $1,911 |
| Testosterone | 23 | $1,865 |
| Testosterone Cypionate | 57 | $1,587 |
| Cefdinir | 105 | $1,521 |
| Potassium Citrate ErPotassium Citrate | 12 | $779 |
| Dutasteride | 44 | $683 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $425 | $724,15568 claims |
| Johnson & JohnsonErleada | $539 | $623,96844 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $550 | $374,649233 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 276 urology providers in Tennessee.
Other urology in Johnson City
- L KnollNashville$2.1M
- David GubinMemphis$1M
- Gautam JayramNashville$1M
- David MorrisHendersonville$871K
- Roger DmochowskiNashville$763K
- Paul EberGermantown$476K
- Ashley TapscottNashville$425K
- Raoul ConcepcionNashville$339K
- Melissa KaufmanNashville$312K
- Mark GreenbergerMemphis$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.